T 0609/12 (Azelastine with fluticasone ester/CIPLA) of 31.05.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T060912.20170531
- Date of decision
- 31 May 2017
- Case number
- T 0609/12
- Petition for review of
- -
- Application number
- 03738280.1
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- COMBINATION OF AZELASTINE AND FLUTICASONE
- Applicant name
- Cipla Limited
- Opponent name
- Glaxo Group Limited
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1)European Patent Convention Art 114(2)European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 12(2)Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 13(1)
- Keywords
- Late-filed evidence
Inventive step - improvement not shown, reformulation of the technical problem
Remittal to the department of first instance for examination of auxiliary requests
Remittal to the department of first instance - no
Late-filed requests submitted during oral proceedings
Late-filed request - admitted (no) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.